July 27, 2016

CTN Webinar Description--Using 68Ga-DOTATATE in the Management of Neuroendocrine Tumor Patients

Date: August 25, 2016 at 3:00pm ET

The U.S. Food and Drug Administration recently approved NETspot®, the first kit for the preparation of gallium 68 DOTATATE injection, a diagnostic agent for positron emission tomography(PET) imaging. {read more here}